Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Are We Following Best Practices for Evaluation of Psychogenic Non-epileptic Seizures (PNES)– We Shouldn’t Need to Reinvent the Wheel
Epilepsy/Clinical Neurophysiology (EEG)
P2 - Poster Session 2 (8:00 AM-9:00 AM)
12-010

To assess for adherence in the best practices for evaluation of Psychogenic non-epileptic seizures (PNES), as pertains to EEG testing.

Hospital-based Video EEG is the gold standard diagnosis for PNES while ambulatory EEG without video was found to be less well suited. We reviewed data at level IV epilepsy center to assess adherence to best practice parameters in patients found to have PNES.

Retrospective case series at a level IV epilepsy center. We analyzed data for patients 18 years and above confirmed to have PNES by EEG including video (VEEG), routine (REEG) and ambulatory (AEEG) from 01/01/2010 to 6/1/2017 with at least one captured event. EEG database was searched for “PNES” meeting the above criteria. We reviewed the order in which tests were obtained, duration and findings of the EEG.

86.70 % of patients had VEEG as the initial test, with 82.5% having 2+ stereotypical events over an average of 2.38 days of EEG. A duration of fewer than 2.0 days tended to be associated with few (1) or no events captured and likely retesting. The presence of epileptiform versus non-epileptiform abnormalities on EEG were associated with 3.50 days versus 2.38 days of EEG. REEG versus AEEG as an initial test in 6.96% and 6.63% respectively.

 

EEG re-testing was seen in 22.78% of the entire population study. Repeat EEG testing was done in 17 (11.68%), 10 (90.91%) and 11 (100.00%) patients who underwent VEEG, REEG and AEEG respectively.  Even after 70% of patients with AEEG had 2 or more events on the initial recording, retesting was required in all.  

VEEG use as the initial test is consistent with best practices, however, AEEG use needs to be limited given prior reports and re-testing seen in this cohort. Two or more days of EEG are associated with a higher yield. 

Authors/Disclosures
Angela Wabulya, MB ChB (Mayo Clinic Arizona)
PRESENTER
Dr. Wabulya has nothing to disclose.
Michael B. Tennison, MD (UNC Chapel Hill) No disclosure on file
William J. Powers, MD, FÂé¶¹´«Ã½Ó³»­ (Duke University School of Medicine) Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
No disclosure on file
Bradley V. Vaughn, MD, FÂé¶¹´«Ã½Ó³»­ (University of North Carolina) Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Âé¶¹´«Ã½Ó³»­ Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with Âé¶¹´«Ã½Ó³»­ that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.